Personalis, Inc.
PSNLNasdaqCIK 1527753HealthcareFiscal year ends Dec 31
Reports and events: 126 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0620:05 ET | 8-K | 8.01 Other events | 0001193125-26-415547 |
| 2026-08-2020:46 ET | 8-K | 8.01 Other events | 0001193125-26-359300 |
| 2026-08-0420:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-332817 |
| 2026-08-0420:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332748 |
| 2026-07-2116:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-310289 |
| 2026-07-2021:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-309101 |
| 2026-07-2013:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-308488 |
| 2026-06-1000:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001805207-26-000003 |
| 2026-05-2020:04 ET | 8-K | 8.01 Other events | 0001193125-26-232533 |
| 2026-05-1320:52 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-221846 |
| 2026-05-1320:03 ET | 8-K | 8.01 Other events | 0001193125-26-221574 |
| 2026-05-0720:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211896 |
| 2026-05-0720:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211850 |
| 2026-04-0220:03 ET | DEF 14A | Proxy statementPeriod 2026-05-12 | 0001193125-26-140038 |
| 2026-03-1720:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-110852 |
| 2026-02-2621:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076615 |
| 2026-02-2621:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076553 |
| 2026-01-0813:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-007037 |
| 2025-11-2822:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-302644 |
| 2025-11-2511:11 ET | 8-K | 8.01 Other events | 0001193125-25-294454 |
| 2025-11-1014:11 ET | 8-K | 8.01 Other events | 0001193125-25-273416 |
| 2025-11-0421:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-264708 |
| 2025-11-0421:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-264690 |
| 2025-09-1216:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001641172-25-027202 |
| 2025-08-2221:55 ET | 8-K | 8.01 Other events | 0000950170-25-110739 |
| 2025-08-0520:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-173575 |
| 2025-08-0520:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102993 |
| 2025-07-0920:17 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-157096 |
| 2025-05-1920:10 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-074346 |
| 2025-05-0620:24 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-064512 |
| 2025-05-0620:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-113820 |
| 2025-04-0320:11 ET | DEF 14A | Proxy statementPeriod 2025-05-16 | 0000950170-25-050392 |
| 2025-02-2722:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029221 |
| 2025-02-2721:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-039219 |
| 2025-01-0721:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-002872 |
| 2024-12-2721:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-285922 |
| 2024-12-1914:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-281696 |
| 2024-11-0621:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122290 |
| 2024-11-0621:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122230 |
| 2024-09-1921:28 ET | 8-K | 8.01 Other events | 0000950170-24-108191 |
| 2024-08-2016:27 ET | SC 13D/A | Ownership report, active investor, amended | 0001493152-24-033275 |
| 2024-08-1613:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-201697 |
| 2024-08-0720:35 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092883 |
| 2024-08-0720:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092712 |
| 2024-07-0313:05 ET | SC 13D | Ownership report, active investor | 0001493152-24-026166 |
| 2024-06-2820:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-031739 |
| 2024-06-2721:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-078618 |
| 2024-05-2120:12 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-062886 |
| 2024-05-0820:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055607 |
| 2024-05-0820:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055585 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.